Fifth, although several studies have explored the involvement of the Hippo pathway in NSCLC, YAP, and TAZ have been found to exhibit suppressive effects in neuroendocrine and hematological tumors [215]. Here, YAP1 is linked to non-small cell lung carcinoma.